Found: 4
Select item for more details and to access through your institution.
Flavaglines target primitive leukemia cells and enhance anti-leukemia drug activity.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 10, p. 1960, doi. 10.1038/leu.2014.93
- By:
- Publication type:
- Article
Alloreactive microenvironment after human hematopoietic cell transplantation induces genomic alterations in epithelium through an ROS-mediated mechanism: in vivo and in vitro study and implications to secondary neoplasia.
- Published in:
- Leukemia (08876924), 2010, v. 24, n. 3, p. 536, doi. 10.1038/leu.2009.284
- By:
- Publication type:
- Article
Human herpesvirus 6-related pure red cell aplasia, secondary graft failure, and clinical severe immune suppression after allogeneic hematopoietic cell transplantation successfully treated with foscarnet.
- Published in:
- Transplant Infectious Disease, 2010, v. 12, n. 5, p. 437, doi. 10.1111/j.1399-3062.2010.00515.x
- By:
- Publication type:
- Article
c-Jun N-terminal kinase activation failure is a new mechanism of anthracycline resistance in acute myeloid leukemia.
- Published in:
- Leukemia (08876924), 2008, v. 22, n. 10, p. 1899, doi. 10.1038/leu.2008.192
- By:
- Publication type:
- Article